{"id":446119,"date":"2021-02-25T16:09:50","date_gmt":"2021-02-25T15:09:50","guid":{"rendered":"https:\/\/hudo.com\/si\/?p=446119"},"modified":"2021-02-25T16:09:50","modified_gmt":"2021-02-25T15:09:50","slug":"pfizer-in-biontech-testirata-morebitni-tretji-odmerek-cepiva","status":"publish","type":"post","link":"https:\/\/hudo.com\/si\/aktualno\/svet\/pfizer-in-biontech-testirata-morebitni-tretji-odmerek-cepiva\/","title":{"rendered":"Pfizer in BioNTech testirata morebitni tretji odmerek cepiva"},"content":{"rendered":"<div id=\"center\">\n<article class=\"articleui\">\n<div class=\"text\">\n<p>Podjetji \u017eelita predvsem ugotoviti, kako u\u010dinkovit bi bil dodaten, obnovitveni odmerek pri prepre\u010devanju oku\u017ebe z novimi, bolj nalezljivimi razli\u010dicami virusa sars-cov-2. Konkretno bodo v raziskavi preverjali imunski odgovor telesa v \u010dasu tretjega odmerka, teden dni kasneje in nato \u0161e po mesecu dni. Sodelovali bodo ljudje iz dveh starostnih skupin &#8211; skupine od 18 do 55 let ter skupine od 65 do 85 let. V okviru raziskave jih bodo nato spremljali \u0161e dve leti, so v dana\u0161nji izjavi za javnost pojasnili vodilni predstavniki obeh podjetij.<\/p>\n<p>V Evropi se trenutno \u0161iri predvsem britanska razli\u010dica novega koronavirusa, prisotni pa sta tudi ju\u017enoafri\u0161ka in brazilska. Vse tri veljajo za bolj nalezljive od prvotne oblike virusa, pojavljajo pa se tudi skrbi, da so, \u0161e posebej ju\u017enoafri\u0161ka, bolj odporne na obstoje\u010da cepiva.<\/p>\n<p>Zaenkrat sicer ni dokazov o tem, da naj bi bilo cepivo pri prepre\u010devanju oku\u017ebe s temi razli\u010dicami manj u\u010dinkovito, je v izjavi poudaril prvi mo\u017e Pfizerja Albert Bourla, a kljub temu se je treba pripraviti na morebitne kasnej\u0161e razli\u010dice, proti katerim obstoje\u010de cepivo morda ne bo nudilo zadostne za\u0161\u010dite. Tudi vodja BioNTecha Ugur Sahin je danes izpostavil, da se \u017eelijo pripraviti &#8220;na razli\u010dne scenarije&#8221;, tako da bodo lahko cepivo, \u010de bo to potrebno, \u010dim hitreje prilagodili.<\/p>\n<p>Poleg omenjene raziskave podjetji razmi\u0161ljata o testiranju nekoliko spremenjene verzije svojega prvotnega cepiva, ki bi ponudila bolj\u0161o za\u0161\u010dito pred oku\u017ebo z ju\u017enoafri\u0161ko mutacijo virusa B.1.351. O tem trenutno potekajo pogovori z regulatorji. Gre namre\u010d za nevarnej\u0161o med sedanjimi mutacijami, saj se izogne nekaterim blokadam protiteles, ki nastanejo ob oku\u017ebi s starej\u0161o razli\u010dico virusa, kar pomeni, da so ljudje, ki so \u017ee bili oku\u017eeni, bolj dovzetni za ponovno oku\u017ebo s to razli\u010dico.<\/p>\n<p>Ameri\u0161ko farmacevtsko podjetje Moderna je v sredo sporo\u010dilo, da je \u017ee za\u010delo testiranje poskusnega cepiva proti mutacijam novega koronavirusa. Hkrati tudi pri Moderni preizku\u0161ajo, ali bi morda proti novim razli\u010dicam virusa zadostovalo cepljenje s tremi namesto z dvema odmerkoma cepiva.<\/p>\n<p>Od vseh mutacij novega koronavirusa tudi to podjetje najbolj skrbi ju\u017enoafri\u0161ka in poskusno cepivo, ki ga bo ameri\u0161ki nacionalni in\u0161titut za zdravje preizkusil na nekaj sto prostovoljcih, je namenjeno predvsem njej.<\/p>\n<\/div>\n<\/article>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Nem\u0161ki BioNTech in ameri\u0161ki Pfizer preizku\u0161ata u\u010dinkovitost cepljenja proti novemu koronavirusu s \u0161e tretjim odmerkom njunega cepiva. Gre za raziskavo, v kateri bodo v ZDA 144 sodelujo\u010dih \u0161est do 12 mesecev po prvem in drugem odmerku cepili \u0161e tretji\u010d. K raziskavi so podjetji vzpodbudile nove razli\u010dice virusa.<\/p>\n","protected":false},"author":8,"featured_media":437944,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18202],"tags":[17584,15940,17583],"source":[4511],"supertag":[16298],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pfizer in BioNTech testirata morebitni tretji odmerek cepiva - Hudo Slovenija<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hudo.com\/si\/aktualno\/svet\/pfizer-in-biontech-testirata-morebitni-tretji-odmerek-cepiva\/\" \/>\n<meta property=\"og:locale\" content=\"sl_SI\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pfizer in BioNTech testirata morebitni tretji odmerek cepiva - Hudo Slovenija\" \/>\n<meta property=\"og:description\" content=\"Nem\u0161ki BioNTech in ameri\u0161ki Pfizer preizku\u0161ata u\u010dinkovitost cepljenja proti novemu koronavirusu s \u0161e tretjim odmerkom njunega cepiva. Gre za raziskavo, v kateri bodo v ZDA 144 sodelujo\u010dih \u0161est do 12 mesecev po prvem in drugem odmerku cepili \u0161e tretji\u010d. K raziskavi so podjetji vzpodbudile nove razli\u010dice virusa.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hudo.com\/si\/aktualno\/svet\/pfizer-in-biontech-testirata-morebitni-tretji-odmerek-cepiva\/\" \/>\n<meta property=\"og:site_name\" content=\"Hudo Slovenija\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/hudo.si\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-25T15:09:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/hudo.com\/si\/wp-content\/uploads\/sites\/2\/2020\/11\/profimedia-0568951124.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1250\" \/>\n\t<meta property=\"og:image:height\" content=\"833\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"M. N., STA\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@hudo_si\" \/>\n<meta name=\"twitter:site\" content=\"@hudo_si\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"M. N., STA\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuti\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/hudo.com\/si\/aktualno\/svet\/pfizer-in-biontech-testirata-morebitni-tretji-odmerek-cepiva\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/hudo.com\/si\/aktualno\/svet\/pfizer-in-biontech-testirata-morebitni-tretji-odmerek-cepiva\/\"},\"author\":{\"name\":\"M. N., STA\",\"@id\":\"https:\/\/hudo.com\/si\/#\/schema\/person\/c2f10ce65d2e6ede2aeda5be2a0611fa\"},\"headline\":\"Pfizer in BioNTech testirata morebitni tretji odmerek cepiva\",\"datePublished\":\"2021-02-25T15:09:50+00:00\",\"dateModified\":\"2021-02-25T15:09:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/hudo.com\/si\/aktualno\/svet\/pfizer-in-biontech-testirata-morebitni-tretji-odmerek-cepiva\/\"},\"wordCount\":390,\"publisher\":{\"@id\":\"https:\/\/hudo.com\/si\/#organization\"},\"keywords\":[\"BioNtech\",\"cepivo proti koronavirusu\",\"Pfizer\"],\"articleSection\":[\"Svet\"],\"inLanguage\":\"sl-SI\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/hudo.com\/si\/aktualno\/svet\/pfizer-in-biontech-testirata-morebitni-tretji-odmerek-cepiva\/\",\"url\":\"https:\/\/hudo.com\/si\/aktualno\/svet\/pfizer-in-biontech-testirata-morebitni-tretji-odmerek-cepiva\/\",\"name\":\"Pfizer in BioNTech testirata morebitni tretji odmerek cepiva - Hudo Slovenija\",\"isPartOf\":{\"@id\":\"https:\/\/hudo.com\/si\/#website\"},\"datePublished\":\"2021-02-25T15:09:50+00:00\",\"dateModified\":\"2021-02-25T15:09:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/hudo.com\/si\/aktualno\/svet\/pfizer-in-biontech-testirata-morebitni-tretji-odmerek-cepiva\/#breadcrumb\"},\"inLanguage\":\"sl-SI\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/hudo.com\/si\/aktualno\/svet\/pfizer-in-biontech-testirata-morebitni-tretji-odmerek-cepiva\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/hudo.com\/si\/aktualno\/svet\/pfizer-in-biontech-testirata-morebitni-tretji-odmerek-cepiva\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/hudo.com\/si\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pfizer in BioNTech testirata morebitni tretji odmerek cepiva\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/hudo.com\/si\/#website\",\"url\":\"https:\/\/hudo.com\/si\/\",\"name\":\"Hudo Slovenija\",\"description\":\"Vse novice iz Slovenije in sveta\",\"publisher\":{\"@id\":\"https:\/\/hudo.com\/si\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/hudo.com\/si\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"sl-SI\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/hudo.com\/si\/#organization\",\"name\":\"VSN Media\",\"url\":\"https:\/\/hudo.com\/si\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sl-SI\",\"@id\":\"https:\/\/hudo.com\/si\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/hudo.com\/si\/wp-content\/uploads\/sites\/2\/2021\/03\/hudo-app-2.png\",\"contentUrl\":\"https:\/\/hudo.com\/si\/wp-content\/uploads\/sites\/2\/2021\/03\/hudo-app-2.png\",\"width\":2185,\"height\":2167,\"caption\":\"VSN Media\"},\"image\":{\"@id\":\"https:\/\/hudo.com\/si\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/hudo.si\",\"https:\/\/twitter.com\/hudo_si\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/hudo.com\/si\/#\/schema\/person\/c2f10ce65d2e6ede2aeda5be2a0611fa\",\"name\":\"M. N., STA\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sl-SI\",\"@id\":\"https:\/\/hudo.com\/si\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f370d38daa10467f755c5c766a4cac20?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f370d38daa10467f755c5c766a4cac20?s=96&d=mm&r=g\",\"caption\":\"M. N., STA\"},\"url\":\"https:\/\/hudo.com\/si\/author\/mana\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pfizer in BioNTech testirata morebitni tretji odmerek cepiva - Hudo Slovenija","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hudo.com\/si\/aktualno\/svet\/pfizer-in-biontech-testirata-morebitni-tretji-odmerek-cepiva\/","og_locale":"sl_SI","og_type":"article","og_title":"Pfizer in BioNTech testirata morebitni tretji odmerek cepiva - Hudo Slovenija","og_description":"Nem\u0161ki BioNTech in ameri\u0161ki Pfizer preizku\u0161ata u\u010dinkovitost cepljenja proti novemu koronavirusu s \u0161e tretjim odmerkom njunega cepiva. Gre za raziskavo, v kateri bodo v ZDA 144 sodelujo\u010dih \u0161est do 12 mesecev po prvem in drugem odmerku cepili \u0161e tretji\u010d. K raziskavi so podjetji vzpodbudile nove razli\u010dice virusa.","og_url":"https:\/\/hudo.com\/si\/aktualno\/svet\/pfizer-in-biontech-testirata-morebitni-tretji-odmerek-cepiva\/","og_site_name":"Hudo Slovenija","article_publisher":"https:\/\/www.facebook.com\/hudo.si","article_published_time":"2021-02-25T15:09:50+00:00","og_image":[{"width":1250,"height":833,"url":"https:\/\/hudo.com\/si\/wp-content\/uploads\/sites\/2\/2020\/11\/profimedia-0568951124.jpg","type":"image\/jpeg"}],"author":"M. N., STA","twitter_card":"summary_large_image","twitter_creator":"@hudo_si","twitter_site":"@hudo_si","twitter_misc":{"Written by":"M. N., STA","Est. reading time":"2 minuti"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/hudo.com\/si\/aktualno\/svet\/pfizer-in-biontech-testirata-morebitni-tretji-odmerek-cepiva\/#article","isPartOf":{"@id":"https:\/\/hudo.com\/si\/aktualno\/svet\/pfizer-in-biontech-testirata-morebitni-tretji-odmerek-cepiva\/"},"author":{"name":"M. N., STA","@id":"https:\/\/hudo.com\/si\/#\/schema\/person\/c2f10ce65d2e6ede2aeda5be2a0611fa"},"headline":"Pfizer in BioNTech testirata morebitni tretji odmerek cepiva","datePublished":"2021-02-25T15:09:50+00:00","dateModified":"2021-02-25T15:09:50+00:00","mainEntityOfPage":{"@id":"https:\/\/hudo.com\/si\/aktualno\/svet\/pfizer-in-biontech-testirata-morebitni-tretji-odmerek-cepiva\/"},"wordCount":390,"publisher":{"@id":"https:\/\/hudo.com\/si\/#organization"},"keywords":["BioNtech","cepivo proti koronavirusu","Pfizer"],"articleSection":["Svet"],"inLanguage":"sl-SI"},{"@type":"WebPage","@id":"https:\/\/hudo.com\/si\/aktualno\/svet\/pfizer-in-biontech-testirata-morebitni-tretji-odmerek-cepiva\/","url":"https:\/\/hudo.com\/si\/aktualno\/svet\/pfizer-in-biontech-testirata-morebitni-tretji-odmerek-cepiva\/","name":"Pfizer in BioNTech testirata morebitni tretji odmerek cepiva - Hudo Slovenija","isPartOf":{"@id":"https:\/\/hudo.com\/si\/#website"},"datePublished":"2021-02-25T15:09:50+00:00","dateModified":"2021-02-25T15:09:50+00:00","breadcrumb":{"@id":"https:\/\/hudo.com\/si\/aktualno\/svet\/pfizer-in-biontech-testirata-morebitni-tretji-odmerek-cepiva\/#breadcrumb"},"inLanguage":"sl-SI","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hudo.com\/si\/aktualno\/svet\/pfizer-in-biontech-testirata-morebitni-tretji-odmerek-cepiva\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/hudo.com\/si\/aktualno\/svet\/pfizer-in-biontech-testirata-morebitni-tretji-odmerek-cepiva\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/hudo.com\/si\/"},{"@type":"ListItem","position":2,"name":"Pfizer in BioNTech testirata morebitni tretji odmerek cepiva"}]},{"@type":"WebSite","@id":"https:\/\/hudo.com\/si\/#website","url":"https:\/\/hudo.com\/si\/","name":"Hudo Slovenija","description":"Vse novice iz Slovenije in sveta","publisher":{"@id":"https:\/\/hudo.com\/si\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hudo.com\/si\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"sl-SI"},{"@type":"Organization","@id":"https:\/\/hudo.com\/si\/#organization","name":"VSN Media","url":"https:\/\/hudo.com\/si\/","logo":{"@type":"ImageObject","inLanguage":"sl-SI","@id":"https:\/\/hudo.com\/si\/#\/schema\/logo\/image\/","url":"https:\/\/hudo.com\/si\/wp-content\/uploads\/sites\/2\/2021\/03\/hudo-app-2.png","contentUrl":"https:\/\/hudo.com\/si\/wp-content\/uploads\/sites\/2\/2021\/03\/hudo-app-2.png","width":2185,"height":2167,"caption":"VSN Media"},"image":{"@id":"https:\/\/hudo.com\/si\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/hudo.si","https:\/\/twitter.com\/hudo_si"]},{"@type":"Person","@id":"https:\/\/hudo.com\/si\/#\/schema\/person\/c2f10ce65d2e6ede2aeda5be2a0611fa","name":"M. N., STA","image":{"@type":"ImageObject","inLanguage":"sl-SI","@id":"https:\/\/hudo.com\/si\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f370d38daa10467f755c5c766a4cac20?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f370d38daa10467f755c5c766a4cac20?s=96&d=mm&r=g","caption":"M. N., STA"},"url":"https:\/\/hudo.com\/si\/author\/mana\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/hudo.com\/si\/wp-json\/wp\/v2\/posts\/446119"}],"collection":[{"href":"https:\/\/hudo.com\/si\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hudo.com\/si\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hudo.com\/si\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/hudo.com\/si\/wp-json\/wp\/v2\/comments?post=446119"}],"version-history":[{"count":1,"href":"https:\/\/hudo.com\/si\/wp-json\/wp\/v2\/posts\/446119\/revisions"}],"predecessor-version":[{"id":446120,"href":"https:\/\/hudo.com\/si\/wp-json\/wp\/v2\/posts\/446119\/revisions\/446120"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hudo.com\/si\/wp-json\/wp\/v2\/media\/437944"}],"wp:attachment":[{"href":"https:\/\/hudo.com\/si\/wp-json\/wp\/v2\/media?parent=446119"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hudo.com\/si\/wp-json\/wp\/v2\/categories?post=446119"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hudo.com\/si\/wp-json\/wp\/v2\/tags?post=446119"},{"taxonomy":"source","embeddable":true,"href":"https:\/\/hudo.com\/si\/wp-json\/wp\/v2\/source?post=446119"},{"taxonomy":"supertag","embeddable":true,"href":"https:\/\/hudo.com\/si\/wp-json\/wp\/v2\/supertag?post=446119"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}